KFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs


Key Findings

  • As a fairly new magnificence of prescribed drugs, to start with licensed to regard sort 2 diabetes, were gaining consideration for his or her use as efficient weight reduction medication, the newest KFF Well being Monitoring Ballot reveals that just about part of adults (45%) say they might in most cases be enthusiastic about taking a protected and efficient prescription weight reduction drug, together with just about six in ten (59%) of those that are these days seeking to drop a few pounds and part (51%) of those that are seeking to lose not up to 10 kilos. About seven in ten adults say they have got heard a minimum of “a bit of” about this new magnificence of weight reduction medication, which come with Ozempic, Wegovy and Mounjaro.
  • Whilst there may be total pastime in taking a prescription weight reduction drug, pastime decreases considerably as soon as persons are requested if they might take a drug administered as regimen injection (23% of all adults would nonetheless have an interest), if it was once no longer coated via their insurance coverage (16%), if it was once no longer licensed via the FDA for weight reduction particularly (16%), or in the event that they heard they will acquire weight again after preventing use (14%).
  • Maximum adults (80%) say that insurance coverage corporations must quilt the price of weight reduction medication for adults who’re obese or overweight, whilst part of adults (53%) say insurance coverage must quilt the price of those medication for somebody who needs them to drop a few pounds. Part of adults proceed to mention that medical insurance must quilt the price of weight reduction medication, even though it intended that per 30 days medical insurance premiums greater for everybody, together with higher stocks of Democrats (62%).
  • Pastime and insist for those new weight reduction medication comes at a time when a majority of the general public say they accept as true with pharmaceutical corporations to increase new medication (75%) and supply dependable details about protection and negative effects (66%) in addition to drug effectiveness (64%) – however a ways fewer adults (22%) say they accept as true with those pharmaceutical corporations to worth their merchandise somewhat. A big majority of adults (83%), together with majorities throughout partisans, see pharmaceutical income as a significant component contributing to the price of prescribed drugs.
  • Notable stocks of adults (28%) file problem affording prescribed drugs, with every other 3 in ten adults (31%) reporting no longer taking their drugs as prescribed previously 12 months because of the associated fee. Decrease source of revenue adults are much more likely than the ones with upper family earning to file experiencing those cost-related prescription drug problems.
  • Majorities throughout partisans say there isn’t sufficient legislation over drug pricing, on the other hand, slightly below a 12 months after the passage of the Inflation Relief Act, few adults within the U.S. are conscious about the regulation’s provisions geared toward lowering the price of prescribed drugs in Medicare. Whilst adults ages 65 and older – the crowd who will probably be maximum suffering from the regulation’s Medicare provisions – are much more likely than more youthful adults to learn about a few of these sides of the regulation, a majority of older adults are nonetheless unaware whether or not those provisions are these days in position. About 4 in ten (44%) of the ones ages 65 and older say they’re conscious about insulin caps for other people with Medicare, and about 3 in ten say they’re conscious about annual out-of-pocket prescription drug limits for other people with Medicare (34%) or the requirement that the government negotiate the cost of some prescribed drugs for other people with Medicare (31%), whilst simply 5% say they’re conscious about consequences for drug corporations for expanding costs quicker than inflation for other people with Medicare.

Public Opinion On A New Magnificence Of Weight Loss Medicine

A brand new magnificence of prescribed drugs, to start with evolved to regard sort 2 diabetes, were garnering an expanding quantity of attention because of their skill to behave as extremely efficient weight reduction medication for obese or overweight adults. This magnificence of gear comprises other medicines, akin to Ozempic, Wegovy, and Mounjaro. The newest KFF Monitoring Ballot examines public pastime and consciousness of those medication in addition to how perspectives alternate as soon as other people listen extra details about the accessibility and management of the medicines.

Seven in ten adults say they have got heard a minimum of “a bit of” a couple of new magnificence of gear getting used for weight reduction, akin to Ozempic, Wegovy, and Mounjaro, with about one in 5 (19%) pronouncing they have got heard “so much” about those medication.

Consciousness of the brand new weight reduction medication is top amongst all teams, however older adults are one of the crucial maximum mindful with a minimum of 8 in ten adults ages 65 and older (79%) pronouncing they have got heard about them. 3 in 4 adults (76%) who’ve been instructed via a physician previously 5 years that they’re obese or overweight also are conscious about this new magnificence of gear getting used for weight reduction. Consciousness may be top amongst adults who’re these days seeking to drop a few pounds, with 3 in 4 (74%) pronouncing they have got heard about those medication.

Whilst maximum adults file having heard a minimum of “a bit of” about this new magnificence of weight reduction medication, only a few file having ever taken any prescription drug to drop a few pounds, with even fewer who file these days taking a prescription drug for weight reduction. Simply 4% of adults say they’re these days taking a prescription drug to drop a few pounds and one in ten say they have got prior to now taken prescribed drugs for weight reduction however don’t seem to be these days the usage of them, leaving about 9 in ten adults (87%) who say they have got by no means taken any prescription weight reduction medication.

General, about six in ten adults (61%) say they’re these days seeking to drop a few pounds, together with 28% who’re seeking to lose greater than 20 kilos. About 4 in ten (39%) adults say a physician or different well being care supplier has instructed them that they’re obese or overweight previously 5 years. Prior use of weight reduction medication may be extra commonplace amongst those teams.

One in ten of those that are these days seeking to lose greater than 20 kilos and a equivalent proportion of adults who’ve been instructed via a physician previously 5 years that they’re overweight or obese say they’re these days taking medicines for weight reduction. An extra one in six amongst every of those teams say they have got taken medicines for weight reduction previously.

Ladies are about two times as most probably as males to mention they have got ever used any prescription drug to drop a few pounds (18% v. 8%) and also are much more likely to mention they’re these days the usage of those medication to drop a few pounds (5% v. 2%). Significantly, girls also are much more likely than males to mention that a physician or different well being care supplier instructed them they have been obese or overweight previously 5 years (47% v. 32%).

Just about part of adults (45%) say they might be enthusiastic about taking a prescription drug to drop a few pounds in the event that they heard that it was once protected and efficient, together with about one in 5 (18%) who say they’re “very .” Ladies are considerably much more likely than males to mention they might be enthusiastic about taking a prescription drug for weight reduction (51% v. 38%). About 4 in ten Black adults (41%), just about part of White adults (45%), and simply over part of Hispanic adults (55%) say they might be enthusiastic about taking a prescription weight reduction drug. Whilst equivalent stocks of Black adults, Hispanic adults and White adults file being instructed via a physician or well being care supplier previously 5 years that they’re obese or overweight, KFF’s analysis of Facilities for Illness Keep an eye on (CDC) information displays that Black and Hispanic adults within the U.S. have the next price of weight problems than White adults. For more information on weight problems charges and racial disparities, see KFF’s coverage watch: What are the Implications of New Anti-Obesity Drugs for Racial Disparities?

The proportion who say they’re enthusiastic about taking prescribed drugs for weight reduction will increase to two-thirds (67%) amongst those that were instructed via a physician or well being care supplier that they’re obese or overweight previously 5 years. As well as, about six in ten (59%) adults who say they’re these days seeking to drop a few pounds say they might be enthusiastic about taking a weight reduction drug.

Pastime in taking a prescription drug for weight reduction is much more commonplace amongst those that say they’re seeking to lose fairly higher quantities of weight, on the other hand, notable stocks of those that are seeking to lose 10 kilos or much less additionally say they might be enthusiastic about taking a protected, efficient prescription drug for weight reduction. About seven in ten (68%) adults who say they’re these days seeking to lose 20 kilos or extra say they might be enthusiastic about taking a prescription drug for weight reduction in the event that they heard it was once protected and efficient, in comparison to about part of adults who’re seeking to lose 10 to twenty kilos (50%) or not up to 10 kilos (51%). However pastime for taking such medicines isn’t restricted to these these days seeking to drop a few pounds; 1 / 4 (23%) of those that say they’re no longer these days seeking to drop a few pounds say they might be enthusiastic about taking a drug to drop a few pounds in the event that they heard it was once protected and efficient.

Whilst notable stocks of adults who say they’re seeking to lose fairly small quantities of weight say they might be enthusiastic about taking a prescription drug for weight reduction in the event that they heard it was once protected and efficient, it’s price noting that some of the fairly new magnificence of gear getting used for weight reduction, Wegovy, which is licensed via the FDA for weight reduction, is intended for power weight control in adults who’re overweight, or adults who’re obese and feature one weight-related situation, akin to sort 2 diabetes.

Whilst about part of adults categorical pastime in taking protected, efficient prescribed drugs for weight reduction, some persons are not after listening to further details about those medication. Very similar to the proportion of adults who’re enthusiastic about taking a drug for weight reduction if it was once protected and efficient, just about part of all adults (44%) proceed to be both “very” or “reasonably” enthusiastic about taking drugs like this if it might be taken it as a tablet.  However pastime drops greater than twenty proportion issues when adults are requested if they might have an interest in the event that they needed to administer it themselves as a weekly injection (23%), if it was once no longer coated via their insurance coverage (16%), or if it was once no longer licensed via the FDA for weight reduction however was once licensed for every other use (16%). Pastime in taking a medicine for weight reduction drops to fourteen% when other people listen they will acquire weight again after preventing use.

8 in ten adults say they believe medical insurance must quilt the price of prescription weight reduction medication for adults who’ve been identified as obese or overweight, whilst about part (53%) of adults say medical insurance must quilt the price of those medication for somebody who needs to take them to drop a few pounds. Part of adults proceed to mention they believe medical insurance must nonetheless quilt those prices even though they heard that it will in most cases build up per 30 days medical insurance premiums for everybody.

Whilst majorities throughout partisans say that medical insurance must quilt the price of prescription weight reduction medication for both somebody who needs them or for adults identified as obese or overweight, higher stocks of Democrats say this (88%) in comparison to independents (81%) and Republicans (77%). Moreover, about six in ten Democrats (62%) say insurance coverage must nonetheless quilt the price of weight reduction medication even on the expense of upper premiums for everybody in comparison to about part of independents (48%) and 4 in ten Republicans (39%).

Whilst huge majorities throughout age teams say medical insurance must quilt the price of prescription weight reduction medication for both somebody who needs them or for adults identified as obese or overweight, other people below the age of 65 are much more likely than the ones ages 65 and older to mention they nonetheless suppose insurance coverage must quilt the price of prescription weight reduction medication even though they heard that it could build up insurance coverage premiums for everybody (53% v. 39%).

Perspectives On Pharmaceutical Corporations And Issues Over Prescription Drug Pricing

Along public pastime in new weight reduction medication and notable stocks of adults pronouncing they believe medical insurance must quilt the price of those medication – even on the expense of accelerating per 30 days premiums for everybody – maximum adults file a loss of accept as true with in pharmaceutical corporations to worth their medication somewhat and say there isn’t sufficient legislation in terms of prescription drug prices. Notable stocks additionally skilled cost-related problems with prescribed drugs previously 12 months, with 3 in ten adults reporting no longer taking their prescription drugs as prescribed because of the associated fee. Maximum adults, on the other hand, are trusting of drug corporations when it comes growing new medication and speaking dependable details about the protection and effectiveness in their medication.

3-quarters (75%) of adults say they accept as true with pharmaceutical corporations both “so much” or “reasonably” to increase new, efficient medication, and simply over six in ten say they accept as true with drug corporations to supply dependable details about the negative effects and protection in their medication (66%) or to supply dependable details about how neatly their medication paintings (64%). Fewer, or about part (48%), of all adults say they accept as true with pharmaceutical corporations to tell the general public temporarily after they be told of a security worry with their medication. Adults are least trusting in terms of drug pricing, with one in 5 (22%) pronouncing they accept as true with drug corporations “so much” or “reasonably” to worth their merchandise somewhat.

Maximum adults, together with majorities throughout partisans, cite income made via pharmaceutical corporations as a “significant factor” contributing to the cost of prescribed drugs. About 8 in ten adults (83%) say income made via pharmaceutical corporations are a “significant factor” contributing to the cost of prescribed drugs, in comparison to fewer who say the price of analysis and construction (54%) or the price of advertising and promoting (45%) are primary contributing elements. Moreover, majorities throughout partisans cite income made via pharmaceutical corporations as the principle issue contributing prescription drug costs, together with 9 in ten Republicans (89%) and equivalent stocks of Democrats (84%) and independents (78%).

Whilst many adults file a loss of accept as true with in pharmaceutical corporations to worth their merchandise somewhat, notable stocks of adults additionally file experiencing issues affording prescribed drugs, with 3 in ten (28%) pronouncing it’s both “reasonably” or “very tough” to have enough money prescribed drugs, together with higher stocks of the ones with annual family earning of much less $40,000 a 12 months (40%).

Any other 3 in ten adults (31%) say they haven’t taken their drugs as prescribed because of charge. This comprises one in 5 adults who say they have got no longer crammed a prescription for a drugs because of the associated fee (21%) or taken an over the counter drug as a substitute of having a prescription crammed as a result of the associated fee, and about one in ten (12%) who say they have got minimize drugs in part or skipped doses of medication as a result of the associated fee previously 12 months.

Decrease source of revenue adults are much more likely than the ones with upper earning to enjoy those cost-related prescription drug problems. Slightly below 4 in ten (37%) of the ones with annual family earning of not up to $40,000 say they haven’t taken their drugs as prescribed because of the associated fee previously 12 months in comparison to 3 in ten (30%) of the ones with annual earning between $40,000 and no more than $90,000 and 1 / 4 (24%) of the ones with earning of $90,000 or extra.

Maximum adults say there must be extra legislation in terms of prescription drug prices. 3 quarters (73%) of adults say there isn’t sufficient executive legislation in terms of proscribing the cost of prescribed drugs, with simply 13% pronouncing there may be “about the correct amount” of legislation on this house. About part (47%) of adults say there isn’t as a lot executive legislation as there must be in terms of ensuring prescribed drugs are protected for other people to make use of, whilst 4 in ten say there may be the correct amount of presidency legislation on this house. The proportion of adults these days pronouncing there may be no longer as a lot legislation as there must be in every of those spaces has greater via about 10 proportion issues since 2021.

Majorities of adults throughout partisans agree that there’s no longer sufficient legislation over prescription drug costs, with 8 in ten Democrats (82%) and simply over two-thirds of Republicans (68%) and independents (67%) pronouncing there isn’t as a lot legislation as there must be in terms of proscribing the cost of prescribed drugs. Very similar to will increase some of the overall inhabitants, the stocks of Democrats and Republicans pronouncing there isn’t sufficient legislation in proscribing the cost of prescribed drugs has greater via about ten proportion issues since 2021.

Part (49%) of adults ages 18 to 64 say there isn’t as a lot legislation as there must be in terms of ensuring prescribed drugs are protected for other people to make use of, whilst two in 5 (40%) of the ones ages 65 and older say there isn’t sufficient legislation on this house. With regards to legislation over prescription drug costs, equivalent stocks of the ones below the age of 65 (73%) and the ones 65 and older (72%) say there isn’t as a lot legislation as there must be.

The Public’s Wisdom of the Inflation Relief Act

At the same time as many adults, irrespective of partisanship or age, say there isn’t sufficient legislation over proscribing prescription drug costs, few adults are conscious about new prescription drug rules incorporated within the Inflation Relief Act (IRA). Signed into regulation in August of 2022 via President Joe Biden, the IRA comprises a number of provisions associated with decreasing prescription drug prices for other people with Medicare. Particularly, the regulation caps the price of insulin for other people with Medicare at $35 a month, calls for the government to barter the cost of some prescribed drugs for other people with Medicare, puts an annual restrict on out-of-pocket prescription drug prices for other people with Medicare, and penalizes drug corporations for expanding costs quicker than the velocity of inflation for other people with Medicare. For more info, see KFF’s issue brief on the IRA’s prescription drug provisions.

Just about a 12 months after being signed into regulation, few adults are conscious about the IRA’s provisions associated with prescription drug prices in Medicare. 1 / 4 of adults say they’re mindful there are federal regulations in position that cap per 30 days insulin prices at $35 for other people with Medicare (25%), that require the government to barter the cost of some prescribed drugs for other people with Medicare (25%), or that position a restrict on annual out-of-pocket drug prices for other people with Medicare (24%). Even fewer adults are mindful there’s a regulation in position that penalizes drug corporations for expanding costs quicker than the velocity of inflation for other people with Medicare (10%).

Adults ages 65 and older – maximum of whom are coated via Medicare– are much more likely than more youthful adults to grasp those rules are these days in position. However nonetheless, fewer than part of older adults are conscious about those provisions. Two times the proportion of older adults (the ones ages 65 and older) are conscious about the cap on per 30 days insulin prices for other people with Medicare (44%) in comparison to the ones below the age of 65 (20%). Older adults also are much more likely than more youthful adults to grasp there’s a regulation that units an annual restrict on out-of-pocket drug prices for other people with Medicare (34% v. 21%) and executive negotiation necessities for some prescribed drugs for other people with Medicare (31% v. 23%). Alternatively, few adults in both age workforce are mindful there’s a regulation in position that penalizes drug corporations for expanding costs quicker than the velocity of inflation (5% of the ones ages 65 and older and 11% of the ones below age 65).



Source link